First-derivative ultraviolet spectrophotometric (Method I) 
INTRODUCTION
Ketoconazole is an imidazole derivative with a wide antifungal spectrum and possesses some antibacterial activity (El-Shabouri et al., 1998; Hardman, Limbird, Gilman, 2001; Korolkovas, 1988) . administration (Abounassif, El-Shazly, 1989; Hardman, Limbird, Gilman, 2001; Korolkovas, 1988) .
Ketoconazole commercially available in several dosage forms for oral and topical administration. Through the oral route, it could provoke hepatotoxicity and interfere with the metabolism of testosterone (Abounassif, ElShazly, 1989; El-Shanawany et al., 1997; Katsambas et al., 1989; Korolkovas, 1988; Low, Wangboonskul, 1999; Roychowdhury, Das, 1996) . Topical ketoconazole formulations have been found to be effective in controlling seborrhoeic dermatitis without producing significant adverse reactions (Katsambas et al., 1989; Roychowdhury, Das, 1996) . It is active against pityrosporum yeasts both "in vitro" and "in vivo" (El-Shabouri et al., 1998) .
Several analytical methods have been developed for quantitative determination of ketoconazole, among them visible spectrophotometry (Abdel-Gawad, 1997), ultraviolet (UV) spectrophotometry (El-Shabouri et al., 1998; Kedor-Hackmann, Nery, Santoro, 1994) , spectrofluorimetry (El-Shanawany et al., 1997) , thin-layer chromatography (Roychowdhury, Das, 1996) , supercritical fluid chromatography with UV detection (AshrafKhorassani, Levy, 1995) , capillary electrophoresis with diode array detection (Arranz et al., 2000) , high performance liquid chromatography (HPLC) using different detection modes such as UV (Al-Meshal, 1989; Abdel-Moety et al., 2002; Heyden et al., 2002) , diode array (Koves, 1995) and electrochemical detection (Hoffman et al., 1988) , and stripping voltametric and polarographic techniques (Arranz et al., 2003) . However, no reference was found using first-derivative UV spectrophotometric determination of ketoconazole in emulsions.
The official compendia (British Pharmacopoeia, 2000; United States Pharmacopeia, 2005) describe analytical methods for quantitative determination of ketoconazole in tablets and oral suspension, however no validated method was found for its quantitative determination in pharmaceutical emulsions.
The objective of this work was to develop sensitive and efficient analytical methods for quantitative determination of ketoconazole in pharmaceutical emulsions. Two methods were developed and validated for this purpose, using first-derivative UV spectrophotometry (Method I) and HPLC (Method II).
MATERIAL AND METHODS

Instrumentation
A Beckman model DU-70 spectrophotometer with quartz cells of 1 cm path length connected to an Epson-Fx 850 printer was used. The HPLC separations were made on a system comprised of a solvent delivery pump (model 480-C), a variable UV detector set at 225 nm connected to an integrator (model CG-200) (Instrumentos Científicos CG Ltda, São Paulo, Brasil). The system was equipped with a manual Rheodyne 
Reference substances, reagents and solutions
Ketoconazole (99.5%) and terconazole (99.2%) active pharmaceutical ingredients were donated by pharmaceutical firms and were used as reference standards without further purification. All reagents and solvents were of analytical grade. The solvents used in the mobile phase were HPLC grade. Distilled water was purified using a Milli-Q ® Plus System (Millipore ® , Milford, MA, USA).
Two sample matrixes were selected for analysis. The simulated emulsion sample (sample 1) was prepared in our laboratory according to the formula given in Table  I . The commercial sample was obtained from a local pharmaceutical firm (sample 2).
METHODS
First-derivative UV Spectrophotometry (Method I)
Methanol solutions in a concentration range from 5.0 to 30.0 µg/mL were prepared to obtain the analytical curve. Absorption intensities were measured at 257 nm First-derivative ultraviolet spectrophotometric and high performance liquid 93 using methanol as blank, scanning velocity was 300 nm/ min and quartz cells of 1 cm path length were used.
An amount equivalent to 25.0 mg of ketoconazole standard was accurately weighed and transferred to a 100 mL volumetric flask. After solubilization in methanol with sonication, the volume was completed with same solvent to obtain a solution containing 250.0 µg of ketoconazole/mL. Six aliquots of this solution from 0.5 to 3.0 mL were transferred to 25 mL volumetric flasks. The volume was completed with methanol and the final concentrations of the solutions were 5.0, 10.0, 15.0, 20.0, 25.0 and 30.0 µg/mL of ketoconazole in respective volumetric flasks. Absorptions of these solutions were determined at 257 nm, using methanol as blank.
For specificity determination of the method, an amount equivalent to 10.0 mg of standard ketoconazole was accurately weighed and transferred to a 100 mL volumetric flask and the volume was completed with methanol. An aliquot of 5.0 mL was transferred to a 25 mL volumetric flask and volume completed with the same solvent to obtain a solution containing 20.0 µg of ketoconazole/mL. An amount of emulsion (500 mg) equivalent to 10 mg of ketoconazole (sample 2) and 500 mg of placebo emulsion (emulsion without ketoconazole) were separately weighed and transferred to three 100 mL volumetric flasks. After adding 80 mL of methanol to each flask, the resulting solutions were sonicated during 15 min, and the volumes completed with same solvent. The solutions were filtered and 5.0 mL aliquots were transferred to 25 mL volumetric flasks and the volumes completed with methanol. These solutions were analyzed by proposed Method I using methanol as blank.
The precision of the method was determined by analyzing three separate standard solutions and ten aliquots of ketoconazole emulsion samples (sample 1 and 2), containing 20.0 µg/mL of ketoconazole each.
To perform the recovery tests an amount of 25.0 mg of ketoconazole standard was weighed and transferred to a 100 mL volumetric flask. The volume was completed with methanol. An amount of 1.25 g of sample 2, equivalent to 25.0 mg of ketoconazole was weighed and transferred to a 100 mL volumetric flask. The drug was solubilized in methanol by sonication for 15 min and volume was completed with the same solvent. The final concentrations of both solutions were 250.0 µg of ketoconazole/mL.
Appropriate volumes of standard solutions were used to spike sample solutions at three concentration levels. The spiked sample solutions were analyzed using the proposed method.
High Performance Liquid Chromatography (Method II)
The mobile phase was constituted of a mixture of triethylamine in methanol An amount of 10.0 mg of ketoconazole standard was accurately weighed and transferred to a 100 mL volumetric flask. After solubilization in methanol with sonication, the volume was completed with same solvent to obtain a solution containing 100.0 µg of ketoconazole/mL. An amount of 25.0 mg of terconazole (internal standard) was weighed and transferred to a 100 mL volumetric flask. After the solubilization, in methanol with sonication, the volume was completed with same solvent. The final concentration was 250.0 µg of terconazole/mL. Seven aliquots of ketoconazole standard solution from 2.0 to 8.0 mL were transferred to 10 mL volumetric flasks and a 2.0 mL aliquot of internal standard was also added to each flask. The volume was completed with mobile phase and the final concentrations of the solutions were 20.0, 30.0, 40.0, 50.0, 60.0, 70.0 and 80.0 µg of ketoconazole/mL, along with 50.0 µg of terconazole/mL. These solutions were analyzed in duplicate and the analytical curve was constructed by plotting concentration of ketoconazole versus corresponding area ratios of ketoconazole and internal standard.
The specificity of the method was analyzed using standard ketoconazole, sample 2 and placebo solutions.
An amount of 10.0 mg of standard ketoconazole was transferred to a 100 mL volumetric flask and volume completed with methanol. An aliquot of 4.0 mL was transferred to a 10 mL volumetric flask, 2.0 mL of internal standard solution (250.0 µg of terconazole/mL) was also added and the volume completed with methanol. The final concentrations were 40.0 µg of ketoconazole and 50.0 µg of terconazole/mL of solution. An amount of sample 2 (1.0 g), equivalent to 20.0 mg of ketoconazole was accurately weighed and transferred to a 100 mL volumetric flask, 80 mL of methanol was added and the solution sonicated for 15 min. The volume was completed with methanol and resultant solution filtered through Whatman filter paper no.1. An aliquot of 2.0 mL of filtrate was transferred to a 10 mL volumetric flask. An aliquot of 2.0 mL of internal standard (250.0 µg/mL) was also added to same flask and the volume was completed with the mobile phase. The final concentrations were 40.0 µg of ketoconazole and 50.0 µg of terconazole/mL of solution. An amount of 1.0 g of placebo was weighed and submitted to same treatment without addition of the internal standard.
In order to calculate the precision of the method three solutions of standard ketoconazole were prepared as described above. The final concentration of resultant solution was 40.0 µg of ketoconazole and 50.0 µg of terconazole/mL. Ten solutions of ketoconazole emulsion (sample 1 and 2) were prepared containing 40.0 µg of ketoconazole and 50.0 µg of terconazole/mL.
To perform the recovery tests 25.0 mg of ketoconazole standard were weighed and transferred to a 100 mL volumetric flask. After solubilization, the volume was completed with methanol to obtain a solution containing 250.0 µg of ketoconazole/mL. An amount of 1.0 g of sample 2 was weighed and transferred to a 100 mL volumetric flask. After the addition of 80 mL of methanol the solution was sonicated during 15 min. The volume was completed with methanol and the solution filtered. The final concentration was 250.0 µg of ketoconazole/mL.
Appropriate volumes of standard and sample solutions were transferred to 25 mL volumetric flasks and analyzed using the proposed method. In all cases, an aliquot of 5.0 mL of terconazole solution containing 250.0 µg/mL was also added.
RESULTS AND DISCUSSION
First-derivative UV Spectrophotometry (Method I)
The first-derivative UV spectrum of ketoconazole, in a range from 211 nm to 295 nm, presented a maximum absorption peak at 257 nm, without any interference from excipients. The method was validated at 257 nm. The analytical curve was constructed in a concentration range from 5.0 to 30.0 µg of ketoconazole/mL. The linearity of the curve was evaluated by linear regression analyses of responses. The standard curve showed linearity within the concentration range studied with a correlation coefficient of 0.9997 (y=2.1x10 ). The precision of the method was reported as relative standard deviation (RSD) ( Table III) . The accuracy of the proposed method was confirmed by the obtained results (Table IV) . Near 100% recovery of ketoconazole from the matrix proves the accuracy of the proposed method. Different excipients used in the formulations (Table I) did not interfere in the analyses using the proposed first-derivative UV spectrophotometric method (Figure 2) . 
High Performance Liquid Chromatography (Method II)
In the preliminary studies several mobile phases were tested. The optimum and efficient separations were obtained when diisopropylamine was substituted by triethylamine (United States Pharmacopeia, 2005) . The chromatograms of standard ketoconazole and terconazole can be observed in Figure 3B and those of sample can be observed in Figure 3C . A base line separation of ketoconazole and terconazole peaks was obtained within approximately 6.0 min. The shorter elution time makes the method especially useful for routine analysis of ketoconazole in pharmaceutical formulations. Analytical curve was constructed in a ). The precision of the method reported as RSD can be observed in Table III . The accuracy of the HPLC method was confirmed by the results showed in the Table IV. The excipients of the emulsion samples did not interfere in either ketoconazole quantitation or in the internal standard peak (Figures 3A and 3C) .
The validation data and sample analyses substantiate the precision, accuracy, specificity and efficiency of the two proposed methods in the determination of ketoconazole in pharmaceutical emulsions.
CONCLUSIONS
Analytical curves were linear within a concentration range from 5.0 to 30.0 μg/mL for Method I and 20.0 to 80.0 μ g/mL for Method II, with correlation coefficients of 0.9997 and 0.9981, respectively.
The proposed first-derivative ultraviolet spectrophotometric (Method I) and reversed phase high performance liquid chromatographic methods (Method II) presented good precision as is evident from intraday repeatability data. The relative standard deviation (RSD) was 0.56% and 0.41% for simulated and commercial emulsion formulations, respectively, using Method I. The corresponding values were 2.13% and 1.25%, respectively, using Method II. The emulsion samples containing ketoconazole can be analyzed with more precision using proposed Method I, though RSD values are acceptable in both cases.
The percentage recovery was 100.1% for the Method I and 100.4% for the Method II and methods could be considered accurate.
The specificity data show that the emulsion excipients do not interfere in the analyses. In this case, the first-derivative zero-crossing spectrophotometric method presents a unique advantage that it permits determination of ketoconazole in pharmaceutical emulsions even in the presence of potential interfering excipients.
Based on these observations it was concluded that the proposed methods can be applied for rapid ketoconazole determination in pharmaceutical emulsions with precision and accuracy. 
RESUMO
